FUJIFILM FC1 Ultrasound System
Device Facts
| Record ID | K160406 |
|---|---|
| Device Name | FUJIFILM FC1 Ultrasound System |
| Applicant | FUJIFILM Sonosite, Inc. |
| Product Code | IYN · Radiology |
| Decision Date | Mar 16, 2016 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 892.1550 |
| Device Class | Class 2 |
| Attributes | Pediatric, 3rd-Party Reviewed |
Indications for Use
The FC1 Ultrasound System is a general purpose ultrasound system and non-continuous patient monitoring platform intended in clinical care by qualified physicians and healthcare professionals for evaluation by ultrasound imaging or fluid flow analysis of the human body. Specific clinical applications and exam types include: Fetal - OB/GYN Abdominal Intra-operative (Abdominal organs and vascular) Pediatric Small Organ (breast, thyroid, testicles, prostate) Neonatal Cephalic Trans-vaginal Musculo-skel. (Convent.) Musculo-skel. (Superfic.) Cardiac Adult Cardiac Pediatric Peripheral Vessel
Device Story
The FUJIFILM FC1 is a software-controlled, general-purpose diagnostic ultrasound system. It acquires and displays high-resolution, real-time ultrasound data using various imaging modes (B-mode, M-mode, Doppler). The system is operated by physicians and healthcare professionals in clinical settings. It processes inputs from compatible transducers to produce visual images and fluid flow analysis, aiding in clinical evaluation and decision-making. The device supports measurements and calculations for obstetrical, cardiac, and volume assessments, and includes ECG acquisition (non-diagnostic). It features wireless image transfer and storage on removable media. The system benefits patients by providing non-invasive diagnostic imaging and guidance for procedures like peripheral nerve blocks.
Clinical Evidence
No clinical studies were required to support the determination of substantial equivalence. Evidence is based on bench testing, including electrical, thermal, mechanical, and EMC safety, biocompatibility (ISO 10993), and acoustic output characterization (IEC 62359, NEMA UD 2).
Technological Characteristics
The system is a software-controlled diagnostic ultrasound device. It supports linear, curved linear, and phased array transducers (1.0-15.0 MHz). Imaging modes include B-mode, M-mode, Tissue Harmonic Imaging, Pulse Inversion Harmonic Imaging, Compound Harmonic Imaging, Spatial Compound Imaging, Color Doppler (Velocity/Power/Directional), and Pulsed/Continuous Wave Doppler. It features a 12.1" LCD, battery/AC power, and 802.11 wireless support. Patient-contact materials comply with ISO 10993. Software follows IEC 62304 life cycle processes.
Indications for Use
Indicated for qualified physicians and healthcare professionals for ultrasound imaging or fluid flow analysis of the human body, including fetal/OB-GYN, abdominal, intra-operative (abdominal/vascular), pediatric, small organ (breast, thyroid, testicles, prostate), neonatal cephalic, trans-vaginal, musculoskeletal (conventional/superficial), adult/pediatric cardiac, and peripheral vessel applications.
Regulatory Classification
Identification
An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
Predicate Devices
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized representation of human profiles facing right, stacked on top of each other. The profiles are black and have a flowing, abstract design. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the profile graphic.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 16, 2016
FUJIFILM Sonosite, Inc. % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street, NW BUFFALO MN 55313
Re: K160406
Trade/Device Name: FUJIFILM FC1 Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: February 12, 2016 Received: February 16, 2016
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Michael D. O'Hara
For
Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
| DEPARTMENT OF HEALTH AND HUMAN SERVICES<br>Food and Drug Administration | Form Approved: OMB No. 0910-0120<br>Expiration Date: January 31, 2017<br>See PRA Statement below. |
|-------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|
| <b>Indications for Use</b> | |
| 510(k) Number (if known) | TBD |
|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device Name | FUJIFILM FC1 Ultrasound System |
| K160406 | |
| Indications for Use (Describe) | The FUJIFILM FC1Ultrasound System is a general purpose ultrasound system intended for use by qualified physicians and healthcare professionals for evaluation by ultrasound imaging or fluid flow analysis of the human body. Specific clinical applications and exam types include: |
| | Fetal - OB/GYN |
| | Abdominal |
| | Intra-operative (Abdominal organs and vascular) |
| | Pediatric |
| | Small Organ (breast, thyroid, testicles, prostate) |
| | Neonatal Cephalic |
| | Trans-vaginal |
| | Musculo-skel. (Convent.) |
| | Musculo-skel. (Superfic.) |
| | Cardiac Adult |
| | Cardiac Pediatric |
| | Peripheral Vessel |
| Type of Use (Select one or both, as applicable) | |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| <div style="text-align: left;"><span style="text-align: left;"></span><label><input checked="checked" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D)</label></div> | <div style="text-align: left;"><span style="text-align: left;"></span><label><input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C)</label></div> |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
***DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.***
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."
| FORM FDA 3881 (8/14) | Page 1 of 1 | PSC Publishing Services (301) 443-6740 EF |
|----------------------|-------------|-------------------------------------------|
|----------------------|-------------|-------------------------------------------|
{3}------------------------------------------------
| Ultrasound System | I<br>db<br>əld |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| S | t ຂຸບ ດາ ລະ ວ່າ ນາ ໄປ ນ ນາ ລະ ຣາ ໄປ ວ |
| | |
| | of the program of the program and the provinsity of the finish of the finish of the finish of the finish of the finish of the finish of the finish of the finish the finish of |
| | əsindən cinsinə aid bitki növü. İstinadlar Qaraqları Qaraqları Qaraqları Qaraqları Qaraqları Qaraqları Qaraqları Qaraqları Qaraqları Qaraqların Qaraqla<br>unon<br>T<br>I<br>- |
| | ה שהונות ה |
| | only of the program and |
| System: | FUJIFILM FC1 Ultrasound System | | | | | | |
|-------------------------------------------------------|------------------------------------------------------------------------------------|---|-----|-----|------------------|-------------------------|------------------|
| Transducer: | N/A | | | | | | |
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | |
| Clinical Application | Mode of Operation | | | | | Combined (Spec.) | Other (Spec.) |
| | B | M | PWD | CWD | Color Doppler | | |
| Ophthalmic | N | N | N | N | N | B+M; B+PWD; B+CD | 1-3,5 |
| Fetal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Abdominal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Abdominal organs and vascular) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Neuro.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Laparoscopic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Pediatric | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Small Organ (breast, thyroid, testicles, prostate) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Neonatal Cephalic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Adult Cephalic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-rectal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Trans-vaginal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Trans-urethral | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Trans-esoph. (non-Card.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Musculo-skel. (Convent.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Musculo-skel. (Superfic.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Intra-luminal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,4,5 |
| Cardiac Adult | N | N | N | N | N | B+M; B+PWD; B+CWD; B+CD | 1-3,5 |
| Cardiac Pediatric | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-esophageal (card.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Peripheral vessel | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| System: | FUJIFILM FC1 Ultrasound System | | | | | | |
| Transducer: | C11xp/8-5 MHz Transducer | | | | | | |
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | |
| Clinical Application | B | M | PWD | CWD | Color<br>Doppler | Combined<br>(Spec.) | Other<br>(Spec.) |
| Ophthalmic | N | N | N | N | N | N | |
| Fetal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Abdominal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Abdominal<br>organs and vascular) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Neuro.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Laparoscopic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Pediatric | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Small Organ (breast, thyroid,<br>testicles, prostate) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Neonatal Cephalic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Adult Cephalic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-rectal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-vaginal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-urethral | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-esoph. (non-Card.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Musculo-skel. (Convent.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Musculo-skel. (Superfic.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-luminal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Cardiac Adult | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Cardiac Pediatric | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-esophageal (card.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Peripheral vessel | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
xibuəddə sidir təbun bəbbə =ヨ :AQ-1 vd bərbələ və şuqilsəibni wən =N
് ക്ലബ്ബം സ്വീകരക്കുന്നത്. അവലംബം പ്രസ്സിന്റെ സമ്പന്ത്രി സമ്പന്ത്രി സ്ഥിതിച്ചിട്ടുണ്ട്.
പ്രവേഷം ക്ലാപ്പിക്കുന്നത്. അവലംബം പ്രസ്സിന്റെ സമ്പന്ത്രി സ്ഥിതിച്ചിട്ടുണ്ട്. പ്രവേശത്
2. Tissue Harmonic Imaging (THI)
3. Issue Doppler Imaging (IDI)
common problem 4: "Steep Needle Rolling"
5. Spatial Compounding
001.108 ЯНЭ IS 109 (2 109) өгப полтаргаач
{4}------------------------------------------------
างอนุธยาราธา 7-8/qx ۲ ( ) — ตาง ค อรป าง) รถบที่ระบุทคโท อย่างอิง : 2-8. ↑ ค่าเร
xibuəddə siyi 1əbun pəbbə =ヨ 'AQ¬ Aq pərcələ vəzirəsi və itanın mən =N
# :stuəmmo 0 lauoitibb A
് കാലിക്കുന്നത് ക്രിസ്ത്രിക്കുന്നത്. അവലംബം പുറത്തേ പ്രവേശങ്ങളും പ്രവിച്ചിത്രവും വിവ്യത്യ വിവ്യക്ഷിക്കുന്നത്.
അവലംബം പല്ലോസ് ക്രിമ്പ് കേരള സ്വാസത്തിന്റെ വിവ്യത്യ വിവ്യവ വിവ
imaging guidance for peripheral nerve block procedures. Color Doppler includes Power/Velocity/Variance.
2. Tissue Harmonic Imaging (THI)
3. Tissue Doppler Imaging (TDI)
4. Strain Rate Imaging
5.: Spatial compounding
2017.108 Яヨコ 12 1999) ອຂU noilqirose19
{5}------------------------------------------------
| System: | FUJIFILM FCT Ultrasound System | | | | | | |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------|---|-----|-----|------------------|---------------------|------------------|
| Transducer: | C35xp/8-3 MHz Transducer | | | | | | |
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | |
| Clinical Application | Mode of Operation | | | | | | Other<br>(Spec.) |
| | B | M | PWD | CWD | Color<br>Doppler | Combined<br>(Spec.) | |
| Ophthalmic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Fetal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Abdominal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Abdominal<br>organs and vascular) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Neuro.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Laparoscopic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Pediatric | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Small Organ (breast, thyroid,<br>testicles, prostate) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Neonatal Cephalic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Adult Cephalic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-rectal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-vaginal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-urethral | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-esoph. (non-Card.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Musculo-skel. (Convent.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Musculo-skel. (Superfic.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-luminal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Cardiac Adult | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Cardiac Pediatric | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Trans-esophageal (card.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Peripheral vessel | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Other (spec.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| System:<br>Transducer:<br>Intended Use: FUJIFILM FCT Ultrasound System<br>C60xf/5-2 MHz Transducer<br>Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | | |
| Clinical Application | Mode of Operation | | | | | | |
| | B | M | PWD | CWD | Color<br>Doppler | Combined<br>(Spec.) | Other<br>(Spec.) |
| Ophthalmic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Fetal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Abdominal | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Abdominal<br>organs and vascular) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-operative (Neuro.) | | | | | | | |
| Laparoscopic | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Pediatric | | | | | | | |
| Small Organ (breast, thyroid,<br>testicles, prostate) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Neonatal Cephalic | | | | | | | |
| Adult Cephalic | | | | | | | |
| Trans-rectal | | | | | | | |
| Trans-vaginal | | | | | | | |
| Trans-urethral | | | | | | | |
| Trans-esoph. (non-Card.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Musculo-skel. (Convent.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Musculo-skel. (Superfic.) | N | N | N | N | N | B+M; B+PWD; B+CD | 1,2,5 |
| Intra-luminal | | | | | | | |
| Other (spec.) | | | | | | | |
| Cardiac Adult | | | | | | | |
| Cardiac Pediatric | | | | | | | |
| Trans-esophageal (card.) | | | | | | | |
| Other (spec.) | | | | | | | |
| Peripheral vessel | | | | | | | |
| Other (spec.) | | | | | | | |
าควบเรทธานี
xibuəddə siyi 1əbun pəbbe =ヨ :AQ¬ vq pərcələ (Isnoivəsd =Ə :uoi)rəsibui wəu =N
# sinə mənin əsasən ən ən ən ən ən ən ən ən ən qalındığı və qalınmışdır. Bu mənist
് കാലിക്കുന്നു. കുറുകയുടെ വിക്കുന്നത്. അവലംബം പ്രവിശ്വീ മത്സ് വിവർശന ക്ഷേത്രം പ്രവിച്ച ക്ലാപ്പോൾ പ്രവേശം കാലാവും പ്രവ
കാലക്കുന്നു. സ്വീമത്തിനും ശ്രമായ പ്രവേശക്ഷേത്രം പ്രവേശക
1. Tissue Harmonic Imaging (THI)
2. ?
3. Tissue Doppler Imaging (TDI)
5. Deep Neural Command
Special Cell Commanding
5. Spatial Compounding
017.108 ЯНЭ IS 1999) ອະປ noitqirose19
{6}------------------------------------------------
าความรายา โ ร-ราชวัง ออน 107 ออน 107 รางบุคคลที่ไป อย่างอิง (1) อุประเทศที่เป็น – ค-ร. ) อุปรโ
xibuəddə siyi 1əbun pəbbe =ヨ :AQ¬ vq pərcələ (Isnoivəsd =Ə :uoi)rəsibui wəu =N
## sinə mənin əsasən ən ən ən ən ən ən ən ən ən qalındığı və qalınmışdır. Bu mənist
് കാലിക്കുന്നത് സമ്മാനം കുറുക്കുന്നത്. അവലംബം പ്രവീശയിക്കുന്നു. പ്രവേശങ്ങളും പ്രവീകരിച്ചു. പ്രവ
കാലക പ്രവേശ ശ്രമായ ശ്രമായ കുറ്റാവും കാലിക്കുന്നു. പ്രവേശക്ഷേത്രം പ്രവേശക്ഷേത്
2. Tissue Harmonic Imaging (THI)
3. Tissue Doppler Imaging (D)
4. Color M-mode Doppler (D)
5. Sealed Needle Forming Compound:
5.
Spatial Compounding
017.108 ЯНЭ IS 1999) ອະປ noitqirose19
{7}------------------------------------------------
| I | י מנוי<br>I<br>) |
|------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | əldə bir şəhərində bir şəhərində bir şəhərində bir şəhərində bir şəhərində bir şəhərində bir şəhərində bir şəhərində bir şəhərində bir şəhərində bir şəhərində qalınmışdır. B<br>ﺪ |
| rəsində məskun və qalınmışdır. Bu mənist | -0" ।<br>ડુ-દ: |
| | - |
| | t<br>l |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | r |
| | suonesibul punoseund ວາງຣຸດບຸຣິຍາ |
| | ﺃﺷﺨﺎﺹ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ<br>C |
| | |
| | əsində kənd. Bu mənist və bir mənist və bir mənist və bir mənist və bir mənist və bir mənist və bir mənist |
| | T<br>I<br>سال الا المحافظ من المحافظ من المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحافظ المحمول |
| | - |
| | <br>------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| | I<br>C |
| | ר38xp/ |
| | |
| | 9-81/ |
| mately<br>sinə aid bitki növü. İstinadlar Respublikası Suranın Suranın Suranın Suranın Suranın Suranın Suranın Suran Filmin Suran Filmin Suranın Suran Suran Suran S<br>resubsuri<br>ənimobda) əvvəl əsasən bir sənələrin əsasən ərazi varilər. (Tornəli) əvirlərəq qalının qalının qalının mənasının mən<br>ാവുന്നും പ്രാമാന് പ്രാഥവില (കുട്ടിട്ടാറും,മാന്യൻ പ്രാഥവുമായിരുന്നു. അവലംബം<br>ə (səbərliqosedir.<br>ാപ്രശസ്ത) വല്യത്തി വല്യത്തിനും പ്രവാഹന്യത്തിനു വലുംബതാവും പുറത്തേക്കും പ്രവാഹം പ്രവാഹം പ്രവാഹം പ്രവാഹം പ്രവ<br>itsoildqA ไธวเนเ<br>ərin fəsiləsinə cinsinə aid bitki növü. İstinadlar Respublikasının fəsiləsinə filmlərin fəsiləsinə filmlərin fəsiləsinə filmlərin fəsiləsinə filmlərin fəsiləsin<br><br>ാ<br>əsinə aid bitki növü. İstinadlar Şahil Mənistan Şəhrin fəsiləsinə filmlərin fəsiləsinə filmlərin fəsiləsinə cinsinə aid bitki növü. İstinadlar Qaranın Qaran məna<br>ətindən (səsinə aid<br>rın suranın suran və mərkəzi və bir və mərkəzi və bir və mərkəzi və bir və mərkəzi və bir və mərkəzi və bir və mərkəzi və bir və mərkəzi və mərkəzi və mərkəzi və qarın qalın<br>ച്ച് അമ്പന്മവുമാ<br>ട്ടവുമുള്ള പ്രശ്ച<br>suimobdA<br>ലവന്നും പുറ<br>ടുടെ പ്രേല<br>വലാ<br>N<br>ZZ<br>ZZ<br>ZZ<br>B<br>מיני מועד באורך בחוק במקום במקום במקום ב<br>N<br>M<br>ZZZ<br>ZZ<br>ZZ<br>0Ma<br>N<br>N<br>ZZ<br>ZZ<br>N<br>മനാ<br>əpoli<br>noitsteqq fo<br>വറിയായ<br>N<br>N<br>ZZ<br>N<br>N<br>N<br>0+8 :000+8 :000+8 :00+<br>0+8;0W9+8;M+<br>0+8 ; W9+8 ;M+<br>0+8 : Wa+8 : Watter : +<br>:0+8;0Ma+8 :M<br>("Əədqəl" ("Əəqqiddən "Qarşıqlı" ("Əsasən" ("Qaraqlarının "Qaranın qalınmışdır. "Qaraqlarının qalınmışdır. "Qaraqlarının qalınmışdır. "Qaraqlarının qalınmışdır. "Qaraqlarını<br>്ച് പ്രാപ്പ് പ്രാപ്പ് പുറത്തിന്റെ പ്രത്യേക്കും പ്രവ്യത്തിന്റെ പ്രത്യേക്കും പ്രവർത്തിച്ചു. പിട്ടുണ്ടു. പ്രത്യേക്കും പ്രവർത്ത<br>Othe<br>ുന്നു. പിട്ടുണ്ട്. വിശ<br>1,255 1,255<br>รี । | | | | | |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|--|--|--|--|
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
|…
